Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-19-176488
Filing Date
2019-06-19
Accepted
2019-06-19 16:16:53
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 d675029d424b4.htm 424B4 1950072
2 GRAPHIC g675029g06u68.jpg GRAPHIC 117082
3 GRAPHIC g675029g13z04.jpg GRAPHIC 92227
4 GRAPHIC g675029g14c91.jpg GRAPHIC 63010
5 GRAPHIC g675029g15u55.jpg GRAPHIC 51050
6 GRAPHIC g675029g26y91.jpg GRAPHIC 133778
7 GRAPHIC g675029g29l69.jpg GRAPHIC 67886
8 GRAPHIC g675029g32y36.jpg GRAPHIC 70171
9 GRAPHIC g675029g57d39.jpg GRAPHIC 71820
10 GRAPHIC g675029g70w60.jpg GRAPHIC 35540
11 GRAPHIC g675029g73i85.jpg GRAPHIC 51411
12 GRAPHIC g675029g81t99.jpg GRAPHIC 54326
13 GRAPHIC g675029g87y36.jpg GRAPHIC 44289
14 GRAPHIC g675029g88y62.jpg GRAPHIC 114981
15 GRAPHIC g675029g89t53.jpg GRAPHIC 62641
  Complete submission text file 0001193125-19-176488.txt   3370146
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-231700 | Film No.: 19906222
SIC: 2834 Pharmaceutical Preparations